December, 2022

article thumbnail

Industry Predictions For 2023

PharmExec

Top industry experts weigh in on what the new year holds for the pharma industry.

119
119
article thumbnail

Set Medication Therapy Management Goals for 2023

Pharmacy Times

Develop New Year's resolutions that include empowering patients, enhancing communication, increasing professional development.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

From chemistry to canvas: What the pharma world can learn from art

PharmaVoice

Art and science are often viewed as diametric opposites, but these industry insiders say their passion for painting blends into their pharma work.

110
110
article thumbnail

Five Things Pharmacists Should Know About Ventilator Associated Pneumonia (VAP)

IDStewardship

In this article a pharmacist with advanced training and experience in infectious diseases discusses five things pharmacists should know about ventilator associated pneumonia (VAP). Authored By: Lucia Rose, PharmD, BCIDP. Article Posted 1 December 2022. It was the fall of 2009; I was a proud PGY-1 resident at UMass Medical Center rounding with a large team in the ICU.

Hospitals 348
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

340B program continues to drive shift in care to more expensive hospital settings

PhRMA

Yet another study highlights the unintended consequences of the 340B program, which is increasing costs for patients and the health care system as a whole. In this case, the Berkeley Research Group (BRG) found that nearly 36% of all Medicare Part B therapy sales occurred at 340B hospitals in 2021 , up nearly 17 percentage points since 2012, meaning care is moving from physician offices and non-340B hospitals to 340B hospitals.

Hospitals 286
article thumbnail

Pharmacists Take Charge During an In-Flight Medical Emergency

Drug Topics

A group of pharmacists rose to the occasion to help a man having a medical emergency aboard a recent United flight bound for Newark, New Jersey.

275
275

More Trending

article thumbnail

Experts Warn of Spread of Lung Infection-Causing Fungi

Pharmacy Times

Traditionally, endemic fungi are characterized by geographical distribution, however, disease-causing fungi may infect people beyond these havens.

170
170
article thumbnail

XBB COVID variant presents a unique threat: study

Fierce Healthcare

XBB COVID variant presents a unique threat: study. fdiamond. Wed, 12/28/2022 - 11:11.

145
145
article thumbnail

Antibiotics For Pediatric Respiratory Tract Infections In The Era Of Amoxicillin Shortages

IDStewardship

In this article a pediatrician puts the 2022-2023 amoxicillin shortage into perspective. . Authored By: Michael Cosimini, M.D. Article Posted 22 December 2022. There is currently a shortage of amoxicillin suspension related to increased demand in the context of a large uptick in pediatric respiratory tract infections. This is a nice time to discuss the valuable role it plays in pediatrics, and alternatives to the medication.

246
246
article thumbnail

Stories from the lab: Researchers discuss innovative treatments for cancers of the blood

PhRMA

The biopharmaceutical industry is one of the most research-intensive of all sectors in the U.S. economy and supports a broad range of STEM jobs through R&D and manufacturing. At the backbone of the biopharmaceutical ecosystem are its researchers. Each day, in labs across the country, these individuals work tirelessly on the front lines of research and development to help bring novel medicines to patients.

264
264
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Assessing Pharmacist Comfort in Recommending OTC Medications for Pregnant Patients

Drug Topics

Knowledge gaps can make OTC medication recommendations for this population a challenge.

232
232
article thumbnail

Opinion: Hospice care needs saving

STAT

Hospice in America is gravely ill. An extensive investigation jointly published by The New Yorker and ProPublica documented outright fraud, predatory practices, and flagrant mistreatment by specific publicly traded and private equity-owned hospice companies.

article thumbnail

Monitoring for Treatment Complications in Patients With Hemophilia A

Pharmacy Times

An array of complications may arise associated with treatment of hemophilia A.

168
168
article thumbnail

UK digital health project aims to tackle dysfunctional breathing

pharmaphorum

A collaboration between academic centres in the UK has won government funding for a digital approach to dysfunctional breathing or dyspnoea, a symptom that affects around 10% of the population. The Engineering and Physical Sciences Research Council (EPSRC) has set aside £400,000 (almost $490,000) for the project, which will help fund work at the Universities of Plymouth, Salford and Stirling, and the Glasgow School of Art.

145
145
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

What Does It Mean To Precept Responsibly & What Is The Precept Responsibly Podcast?

IDStewardship

**ARTICLE UNDER CONSTRUCTION**. In this article an experienced pharmacist discusses the concept of precepting responsibility and the new Precept Responsibly Podcast. pic pending. Authored by: Spencer Sutton, Pharm.D., ??other?? Article Posted XX December 2022. Few Receive Extensive Education On Precepting In Pharmacy. The role of the preceptor is diverse, encompassing didactic education, experiential learning, career development, and innumerable other components all with goal of developing compe

article thumbnail

In their own words: Insured Americans support policy reforms that address access and affordability concerns

PhRMA

A survey of more than 5,000 Americans conducted with Ipsos found that insured Americans want better health care coverage. These insights come from the third installment of the Patient Experience Survey and show how Americans favor policy solutions that improve their ability to navigate and access their care by seeking to remove barriers imposed by insurers and middlemen such as pharmacy benefit managers (PBMs).

Insurance 258
article thumbnail

Research Praises Shingles Vaccine Efficacy

Drug Topics

The shingles vaccine appears to confer long-term immunity, according to research.

Vaccines 226
article thumbnail

STAT+: Nine in 10 health care companies with financial stress are owned by private equity

STAT

Almost 90% of the health care companies deemed to be under financial stress by a leading credit rating agency are owned by private equity , a stark indicator of the toll financial investors have taken on a vital sector. The striking finding is part of a new Moody’s Investors Service report released this week that shows broad turbulence throughout an industry weakened by private equity’s practice of loading companies with debt, making them less resilient to challenges like Covid-19,

Hospitals 145
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Machine Learning Helps Predict Which Patients Respond to Immunotherapy

Pharmacy Times

DeepTCR system showed efficacy as a predictive clinical tool and provided information on the biological mechanisms that underlie how patients respond to immunotherapy.

165
165
article thumbnail

Pediatricians send an SOS to rest of medical community

Fierce Healthcare

Pediatricians send an SOS to rest of medical community. fdiamond. Thu, 12/08/2022 - 07:59.

145
145
article thumbnail

Moderna and UK government sign deal to establish mRNA facility

Pharmaceutical Technology

Moderna and the UK government have entered a ten-year strategic collaboration to build a messenger ribonucleic acid (mRNA) research, development and manufacturing facility in the country. The latest development comes after the parties announced an agreement in principle in June this year. This Moderna Innovation and Technology Centre (MITC) is expected to offer access to a locally produced future mRNA vaccine portfolio against respiratory viruses, subject to regulatory evaluation and licensure.

Vaccines 140
article thumbnail

Using traditional HTAs to determine coverage threatens patient access to medicine

PhRMA

Concerns about the cost of health care have led to calls for the use of health technology assessments or HTAs by the federal government. This would allow government agencies to make important decisions about patient access to health care based on their determination of the value of new tests and treatments.

225
225
article thumbnail

Early and Intense Flu Season Revs Up

Drug Topics

Flanked by RSV and COVID-19, flu season started early and rates of transmission are high throughout the country.

220
220
article thumbnail

STAT+: Alzheimer’s researchers try out an unfamiliar sensation: optimism

STAT

SAN FRANCISCO — Scientific meetings about Alzheimer’s disease can be funereal affairs, with researchers from around the world gathering in hopes that the latest in a long line of negative clinical trials might light the path to a long-awaited success. This year was different. Nearly 2,000 people showed up to the Clinical Trials in Alzheimer’s Disease meeting, a conference record, to hear about lecanemab, a drug from Eisai and Biogen that appears to have broken the decades-lo

145
145
article thumbnail

2023 Pharmacy Forecast Predicts Artificial Intelligence Can Help Reshape Health-Systems

Pharmacy Times

Increasing workplace diversity, addressing health disparities, and overcoming disruptions from COVID-19 are considered top goals among pharmacy stakeholders.

160
160
article thumbnail

2023 forecast: Health tech tools begin constructing the Alzheimer's treatment plan

Fierce Healthcare

2023 forecast: Health tech tools begin constructing the Alzheimer's treatment plan. aburky. Fri, 12/16/2022 - 17:17.

142
142
article thumbnail

Pfizer, Sanofi settle first California Zantac case slated for trial: report

Fierce Pharma

Pfizer, Sanofi settle first California Zantac case slated for trial: report. zbecker. Thu, 12/22/2022 - 12:38.

139
139
article thumbnail

ICYMI: PhRMA COO Lori Reilly speaks about the health care agenda for the next Congress

PhRMA

With a divided Congress, bipartisan action will be necessary to move the needle on health care policy. On December 7, 2022, PhRMA sponsored the Axios event, “ The Post-Midterm Health Care Agenda ,” where I participated in a View from the Top segment with Nicholas Johnston, publisher of Axios. We discussed PhRMA’s focus on passing the PASTEUR Act in the last few weeks of 2022, and laid out PhRMA’s priorities heading into 2023 that will support and protect patients.

Insurance 224
article thumbnail

Pediatric Vaccine Education Can Improve Pharmacist Knowledge, Confidence

Drug Topics

Not every pharmacist may feel comfortable administering vaccines to children, but education could help.

Vaccines 220
article thumbnail

STAT+: Moderna says cancer vaccine reduces melanoma’s return by 44%

STAT

An experimental cancer vaccine being developed by the biotechnology firm Moderna and the drug giant Merck reduced the risk that melanoma would return after surgery or that patients would die by 44%, the company said. The data, made public in a press release, represent the first evidence of an effective individualized cancer vaccine based on mRNA, the technology used in the Covid shots.

Vaccines 144
article thumbnail

Study Results Show Direct Evidence of Serotonin Disruption Linked With Depression

Pharmacy Times

First direct evidence of diminished 5-HT release proves hypothesis, according to a new analysis published in Biological Psychiatry.

153
153
article thumbnail

2023 forecast: Pharmacists push to take on a greater role in patient care

Fierce Healthcare

2023 forecast: Pharmacists push to take on a greater role in patient care. pminemyer. Fri, 12/16/2022 - 12:39.

article thumbnail

Four ways Biogen is tackling digital innovation in neurological disease

pharmaphorum

Digital transformation in pharma is not a singular endeavour. It can mean everything from patient-facing disease management apps and wearables to background AI dramatically altering drug discovery or radiological imaging. So, when a life sciences company embarks on a project of digital transformation or innovation, it’s really embarking on multiple projects that span the wide world of pharmaceutical operations.

Hospitals 137